广誉远龟龄集品牌怎么样 申请店铺

更新时间:2024-10-29
广誉远龟龄集是哪个国家的品牌?「广誉远龟龄集」是 山西广誉远国药有限公司 旗下著名品牌。该品牌发源于山西,由创始人张斌在1998-02-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
广誉远龟龄集怎么样

广誉远始创于明嘉靖二十年(公元1541年),距今已有473年的历史,其间历经广盛号药店、广升聚、广升蔚、广升誉、广升远、山西中药厂、山西广誉远等十几个商号药厂更迭。在清代曾与广州陈李济(1600年创建)、北京同仁堂(1669年创建)、杭州胡庆余堂(1874年创建)并称为“四大药店”,现为山西省中药企业典范,并在2006年成为首批被中华人民共和国商务部认定的“中华老字号”企业。

广誉远主导产品“龟龄集”和“定坤丹”,是中华中医药宝库珍藏的养生至宝,是博大精深的中医药文化的智慧结晶,现为国家级保密处方,分别在2008年和2011年被中华人民共和国国务院评为国家级非物质文化遗产。龟龄集、定坤丹,“御用圣品”的宫廷出身,数百年的药用历史,深刻佐证了其功效卓著;多位皇帝的相关御批,真实确凿的史料档案,更显其品味尊贵。包括龟龄集、定坤丹在内,广誉远系列产品荣获众多国际级奖项、国家级荣誉,在国际传统医药界有深远影响。

广誉远拥有丰富的产品服务群,有丸剂、胶囊剂、酒剂、片剂、颗粒剂、散剂、口服液、煎膏剂共八个剂型,继承着龟龄集、定坤丹、安宫牛黄丸、牛黄清心丸、六味地黄丸、乌鸡白凤丸等103种中药古方及炮制工艺,从方剂、配伍、选材、炮制等诸多方面,承载并展现着中华中医药文化的核心精神与巨大价值。

“尊德贵生,传承创新”是广誉远的企业理念,广誉远坚定地以文化为先导,专注于中医药领域,坚持“继承与创新”的发展策略,充分利用企业内部的产品资源,通过持续的品牌建设和创新营销,走出“特色”道路,努力打造“人无我有,人有我优,做中国最具特色的国药”之企业形象,并在未来五年内,推出精品中药“百家千店”工程,在全国范围内建立100家国医馆、1000家国药堂,包括人参、鹿茸、枸杞、西红花、地黄、肉苁蓉、参等九大GAP养植基地。

473年来,广誉远严苛制药,精益求精,秉承“修合虽无人见,存心自有天知”的古训,遵循“非义而为,一介不取;合情之道,九百何辞”的准则,恪守诚信自律的晋商精神,以信誉为根本,“以义制利”铸就了百年老店的历久弥新。

2003年,由全国著名的大型现代化医药企业——西安东盛集团投资控股,结合现代管理运营理念,将广誉远传统老店,发展成为集中成药研发、生产、销售于一体的高科技现代化制药企业。在国家“十二五规划”对中医药行业的明确指导下,在祖国全面建设小康社会的新时期,在中华民族伟大复兴的历史时刻,广誉远以精品养生中药回馈社会大众,开创智慧养生的新纪元。广誉远作为中国非物质文化遗产的传承者,将为振兴传统中医药文化,贡献应尽的社会责任与历史使命,树立起中医药文化的全新价值。

Guangyuyuan was founded in the 20th year of Jiajing, Ming Dynasty (1541 A.D.), which has a history of 473 years. During this period, guangyuyuan has experienced the change of more than ten famous pharmaceutical companies, such as Guangsheng drugstore, guangshengju, guangshengwei, guangshengyu, guangshengyuan, Shanxi Traditional Chinese medicine factory and Shanxi guangyuyuan. In the Qing Dynasty, it was named as "four drugstores" together with Chen Liji in Guangzhou (founded in 1600), Tongrentang in Beijing (founded in 1669) and Hu qingyutang in Hangzhou (founded in 1874). It is now a model of traditional Chinese medicine enterprises in Shanxi Province, and became one of the first batch of "old Chinese brand" enterprises recognized by the Ministry of Commerce of the people's Republic of China in 2006. Guangyuyuan's leading products "Guilingji" and "dingkundan" are the treasure of health preservation in the treasure house of traditional Chinese medicine, and the wisdom crystallization of extensive and profound traditional Chinese medicine culture. They are now state-level secret prescriptions, and were rated as national intangible cultural heritage by the State Council of the people's Republic of China in 2008 and 2011 respectively. Guilingji, dingkundan, the Royal origin of "imperial holy product", and hundreds of years of medicinal history, have proved its remarkable efficacy; the relevant imperial approvals of several emperors, authentic historical data files, show its taste and dignity. Including Guilingji and dingkundan, guangyuyuan series products have won many international and national awards, and have a profound influence in the international traditional medicine industry. Guangyuyuan has a wealth of product service groups, including eight dosage forms of pills, capsules, liquors, tablets, granules, powders, oral liquids and decoctions. It inherits 103 traditional Chinese medicine prescriptions and processing technologies, including Guilingji, dingkundan, Angongniuhuang, Niuhuang Qingxin, Liuwei Dihuang, Wuji Baifeng, etc., and carries and manufactures from many aspects, such as prescriptions, compatibility, material selection and processing It shows the core spirit and great value of Chinese traditional medicine culture. "Respecting morality, valuing health, inheriting innovation" is guangyuyuan ' In the next five years, we will launch the project of "one hundred thousand stores" of high-quality traditional Chinese medicine, and set up 100 national medicine halls and 1000 national medicine halls nationwide, including nine GAP cultivation bases including ginseng, antler, Lycium, crocus, rehmannia, Cistanche deserticola and ginseng. In the past 473 years, guangyuyuan has been strict in pharmaceutical industry, striving for perfection, adhering to the ancient motto of "no one can see the mending, no one can take it; the way to be reasonable, nine hundred words", abiding by the spirit of integrity and self-discipline of Shanxi merchants, taking reputation as the foundation, and "making profits by righteousness" has made the century old shop new for a long time. In 2003, Xi'an Dongsheng Group, a famous modern pharmaceutical enterprise in China, invested and held the shares, combined with the modern management and operation concept, and developed guangyuyuan traditional old store into a high-tech modern pharmaceutical enterprise integrating the research and development, production and sales of patent medicine. Under the clear guidance of the 12th Five Year Plan for the industry of traditional Chinese medicine, in the new era of building a well-off society in an all-round way in the motherland, and at the historical moment of the great rejuvenation of the Chinese nation, it is well-known for giving back to the public with high-quality health care traditional Chinese medicine and creating a new era of intelligent health care. Guangyuyuan, as the inheritor of Chinese intangible cultural heritage, will contribute to the revitalization of traditional Chinese medicine culture, social responsibility and historical mission, and establish a new value of Chinese medicine culture.

本文链接: https://brand.waitui.com/90f4e668b.html 联系电话:03546225518

千城特选小程序码

7×24h 快讯

东方雨虹:拟5亿元-10亿元回购股份用于注销

36氪获悉,东方雨虹公告,拟5亿元-10亿元回购股份,用于注销并减少公司注册资本。回购价格不超过19.30元/股。

22分钟前

美股大型科技股盘前普涨,谷歌涨超2%

36氪获悉,美股大型科技股盘前普涨,截至发稿,谷歌涨超2%,英伟达、亚马逊、Meta涨超1%,微软涨0.91%,特斯拉涨0.53%,苹果涨0.51%。

22分钟前

热门中概股美股盘前普涨,B站涨超4%

36氪获悉,热门中概股美股盘前普涨,截至发稿,B站涨超4%,小鹏汽车涨超3%,爱奇艺、蔚来涨超2%,阿里巴巴、京东、拼多多、百度涨超1%。

22分钟前

2连板申科股份:近期公司经营情况正常,内外部经营环境未发生重大变化

36氪获悉,申科股份公告,公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息。近期公司经营情况正常,内外部经营环境未发生重大变化。公司10月24日公告,公司控股股东、实际控制人何全波拟将其持有公司全部股份42187466股股权(无限售流通股,占公司总股本的28.12%)股份以公开征集意向受让方方式进行协议转让。

22分钟前

2024年10月票房破35亿

36氪获悉,据灯塔专业版,截止10月28日20时48分,2024年10月总票房(含预售)突破35亿,《志愿军:存亡之战》《浴火之路》《749局》暂列票房前三位。​​​

22分钟前

本页详细列出关于广誉远龟龄集的品牌信息,含品牌所属公司介绍,广誉远龟龄集所处行业的品牌地位及优势。
咨询